Cytokine Release Syndrome Results in Reduced AML Killing By CD123 CAR T Cells

被引：4

作者：

Bhagwat, Anand S. ^{[1
,2
]}

Torres, Leonel ^{[3
]}

Shestova, Olga

Shestov, Maksim ^{[4
,5
]}

Frey, Noelle V. ^{[5
]}

Hexner, Elizabeth O. ^{[5
]}

Luger, Selina M. ^{[6
]}

Loren, Alison W. ^{[7
]}

Martin, Mary Ellen ^{[5
]}

McCurdy, Shannon R. ^{[5
]}

Perl, Alexander ^{[5
]}

Stadtmauer, Edward A. ^{[8
]}

Mangan, James K. ^{[9
]}

Brogdon, Jennifer ^{[10
]}

Fraietta, Joseph A. ^{[1
]}

Hwang, Wei-Ting ^{[11
]}

Siegel, Don L. ^{[2
]}

Kenderian, Saad S. ^{[12
]}

Porter, David L. ^{[13
]}

June, Carl ^{[3
]}

Gill, Saar ^{[5
]}

机构：

[1] Childrens Hosp Philadelphia, Philadelphia, PA USA

[2] Univ Penn, Philadelphia, PA USA

[3] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[4] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[5] Univ Penn, Div Hematol Oncol, Dept Med, Philadelphia, PA USA

[6] Univ Penn, Perelman Sch Med, Hosp, Philadelphia, PA USA

[7] Perelman Ctr Adv Med, Cellular Therapy & Transplantat, Philadelphia, PA USA

[8] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[9] UCSD, Moores Canc Ctr, La Jolla, CA USA

[10] Novartis Inst Biomed Res, Cambridge, MA USA

[11] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA USA

[12] Mayo Clin, Div Hematol, Rochester, MN USA

[13] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-182104

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] CD123 CAR T cells for the treatment of myelodysplastic syndrome
Stevens, Brett M.
Zhang, Wei
Pollyea, Daniel A.
Winters, Amanda
Gutman, Jonathan
Smith, Clayton
Budde, Elizabeth
Forman, Stephen J.
Jordan, Craig T.
Purev, Enkhtsetseg
[J]. EXPERIMENTAL HEMATOLOGY, 2019, 74 : 52 - 63
[2] Azacytidine Sensitizes AML Cells for Effective Elimination By CD123 CAR T-Cells
El Khawanky, Nadia
Hughes, Amy
Yu, Wenbo
Taromi, Sanaz
Clarson, Jade
Lopez, Angel F.
Brown, Michael P.
Duyster, Justus
Hughes, Timothy P.
White, Deborah L.
Yong, Agnes S. M.
Zeiser, Robert
[J]. BLOOD, 2019, 134
[3] Allogenic CAR T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML)
Galetto, Roman
Lebuhotel, Celine
Francon, Patricia
Gouble, Agnes
Smith, Julianne
[J]. MOLECULAR THERAPY, 2015, 23 : S166 - S166
[4] ALLOGENIC ADOPTIVE IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA (AML) BY TARGETING CD123 WITH CAR T-CELLS
Galetto, R.
Lebuhotel, C.
Francon, P.
Gouble, A.
Smith, J.
[J]. HAEMATOLOGICA, 2015, 100 : 172 - 172
[5] Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy
Jacobs, Kenneth
Viero, Cedric
Godwin, John
Baughman, Jan
Sun, Jichao
Ying, Kang
Muth, John
Hong, Shengyan
Vey, Norbert
Sweet, Kendra L.
Uy, Geoffrey L.
Ravandi, Farhad
Foster, Matthew C.
Rizzieri, David A.
Arellano, Martha L.
Rettig, Michael P.
Topp, Max S.
Huls, Gerwin
Lelievre, Helene
Paolini, Stefania
Ciceri, Fabio
Carrabba, Matteo Giovanni
Lowenberg, Bob
DiPersio, John F.
Wigginton, Jon
Davidson-Moncada, Jan K.
[J]. BLOOD, 2018, 132
[6] Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape
Xie, Danni
Jin, Xin
Sun, Rui
Zhang, Meng
Lu, Wenyi
Cao, Xinping
Guo, Ruiting
Zhang, Yi
Zhao, Mingfeng
[J]. TRANSLATIONAL ONCOLOGY, 2023, 34
[7] Improvement in Cytokine Release Syndrome Management for the Treatment of AML Patients with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy
Bakkacha, Ouiam
Uy, Geoffrey L.
Aldoss, Ibrahim
Foster, Matthew C.
Sallman, David A.
Sweet, Kendra L.
Rizzieri, David A.
Sayre, Peter H.
Advani, Anjali S.
Emadi, Ashkan
Wieduwilt, Matthew J.
Vey, Norbert
Ciceri, Fabio
Carrabba, Matteo Giovanni
Moyo, Tamara
Arellano, Martha L.
Godwin, John E.
Lowenberg, Bob
Huls, Gerwin
Ravandi, Farhad
Tran, Kathy
Muth, John
Baughman, Jan
Jongen-Lavrencic, Mojca
Timmeny, Erin
Topp, Max S.
Paolini, Stefania
Guo, Kuo
Curtis, Teia
Zhao, Jian
Wigginton, Jon
Bonvini, Ezio
Walter, Roland B.
Davidson, Jan
DiPersio, John F.
Jacobs, Kenneth
[J]. BLOOD, 2019, 134
[8] Optimizing CD123-CAR T Cells for the Adoptive Immunotherapy of AML
Riberdy, Janice
Zhou, Sheng
Zheng, Fei
Hoehamer, Young-In Kim
Moore, Jennifer
Vaidya, Abishek
Throm, Robert
Ryu, Byoung
Gottschalk, Stephen
Velasquez, Mireya Paulina
[J]. MOLECULAR THERAPY, 2019, 27 (04) : 271 - 272
[9] FULLY HUMAN CD123 CAR T CELLS IRRADICATE AML IN PRE-CLINICAL MODELS AND EXHIBIT A FAVORABLE SAFETY PROFILE
Liang, Genqing
Hu, Peirong
Ngoc Tran
Mahmud, Hasan
Dash, Pradyot
Schneider, Dina
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A268 - A268
[10] Allogenic CAR T-Cells Targeting CD123 Effectively Eliminate Myeloid Leukemia Cells
Galetto, Roman
Lebuhotel, Celine
Gouble, Agnes
Bank, Alexander
Roboz, Gail J.
Guzman, Monica L.
Smith, Julianne
[J]. MOLECULAR THERAPY, 2016, 24 : S157 - S158

← 1 2 3 4 5 →